<code id='E0EE7B74B2'></code><style id='E0EE7B74B2'></style>
    • <acronym id='E0EE7B74B2'></acronym>
      <center id='E0EE7B74B2'><center id='E0EE7B74B2'><tfoot id='E0EE7B74B2'></tfoot></center><abbr id='E0EE7B74B2'><dir id='E0EE7B74B2'><tfoot id='E0EE7B74B2'></tfoot><noframes id='E0EE7B74B2'>

    • <optgroup id='E0EE7B74B2'><strike id='E0EE7B74B2'><sup id='E0EE7B74B2'></sup></strike><code id='E0EE7B74B2'></code></optgroup>
        1. <b id='E0EE7B74B2'><label id='E0EE7B74B2'><select id='E0EE7B74B2'><dt id='E0EE7B74B2'><span id='E0EE7B74B2'></span></dt></select></label></b><u id='E0EE7B74B2'></u>
          <i id='E0EE7B74B2'><strike id='E0EE7B74B2'><tt id='E0EE7B74B2'><pre id='E0EE7B74B2'></pre></tt></strike></i>

          entertainment

          focus

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs
          Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

          LongtimeBluebirdBioCEONickLeschlyWendyMaeda/TheBostonGlobeSometwoyearsaftersplittingbiotechcompanyBl

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Acelyrin, a rare IPO success, stumbles in its first big test

          MarkLennihan/APThebiotechcompanyAcelyrin,whichraisedmorethan$500millioninanIPOthisyear,ranintoitsfir